Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin

Clinical Chemistry

Volumn 55, Issue 8, 2009, Pages 1484-1491

  Sturgeon, Catharine M ^a   Berger, Peter ^b   Bidart, Jean Michel ^c   Birken, Steven ^d   Burns, Chris ^e   Norman, Robert J ^f   Stenman, Ulf Håkan ^g  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Columbia University ^*  (United States)

^e NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; CALIBRATION; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; IMMUNOASSAY; MOLECULAR RECOGNITION; QUALITY CONTROL; SERUM; STANDARD; WORLD HEALTH ORGANIZATION;

CALIBRATION; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; HUMANS; IMMUNOASSAY; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; REFERENCE STANDARDS; WORLD HEALTH ORGANIZATION;

EID: 68149169590     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.124578     Document Type: Article

References (26)

1. Stenman UH, Bidart JM, Birken S, Mann K, Nisula B, O'Connor J. Standardization of protein immunoprocedures: choriogonadotropin (CG). Scand J Clin Lab Invest Suppl 1993;216:42-78.
2. Sturgeon CM, Ellis AR. Standardization of FSH, LH and hCG-current position and future prospects. Mol Cell Endocrinol 2007;260-2:301-309
3. Birken S, Berger P, Bidart JM, Weber M, Bristow A, Norman R, et al. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin Chem 2003;49:144-154 (Pubitemid 36078564)
4. Bristow A, Berger P, Bidart JM, Birken S, Norman R, Stenman UH, Sturgeon C. Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin. Clin Chem 2005; 51:177-182 (Pubitemid 40024028)
5. World Health Organization. 51st meeting of WHO Expert Committee on Biological Standardization. November 2001. WHO Technical Report Series 924. http://whqlibdoc.who.int/trs/WHO-TRS-910. pdf. (Accessed May 31, 2009).
6. Storring PL, Gaines-Das RE, Bangham DR. International Reference Preparation of human chorionic gonadotrophin for immunoassay: potency estimates in various bioassay and protein binding assay systems; and International Reference Preparations of the alpha and beta subunits of human chorionic gonadotrophin for immunoassay. J Endocrinol 1980;84:295-310.
7. Stenman UH, Alfthan H, Hotakainen K. Human chorionic gonadotropin in cancer. Clin Biochem 2004;37:549-561
8. Sturgeon CM, McAllister EJ. Analysis of hCG: clinical applications and assay requirements. Ann Clin Biochem 1998;35:460-491 (Pubitemid 28349650)
9. Muller MM. Implementation of reference systems in laboratory medicine. Clin Chem 2000;46: 1907-1909
10. Alfthan H, Haglund C, Roberts P, Stenman UH. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992;52:4628-4633
11. Cao ZT, Rej R. Are laboratories reporting serum quantitative hCG results correctly? Clin Chem 2008;54:761-764
12. Seth J, Sturgeon CM, al-Sadie R, Hanning I, Ellis AR. External quality assessment of immunoassays of peptide hormones and tumour markers: principles and practice. Ann Ist Super Sanita 1991; 27:443-452
13. Sturgeon C, Ellis AR, Al-Sadie R. UK NEQAS for peptide hormones: annual review for 2004. Edinburgh: UK NEQAS; 2005. p 52-63.
14. Sturgeon C, Ellis AR, Al-Sadie R. UK NEQAS for peptide hormones: annual review for 2008. Edinburgh: UK NEQAS; 2009. p 57-60.
15. Miller WG, Myers GL, Rej R. Why commutability matters. Clin Chem 2006;52:553-554
16. Berger P, Sturgeon C. Human chorionic gonadotropin (hCG) isoforms and their epitopes: diagnostic utility in pregnancy and cancer. Expert Opinion 2008;2:1237-1264
17. Mann K, Saller B, Hoermann R. Clinical use of HCG and hCG beta determinations. Scand J Clin Lab Invest Suppl 1993;216:97-104. (Pubitemid 23213293)
18. Alfthan H, Haglund C, Dabek J, Stenman UH. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the betasubunit in serum and urine of men and nonpregnant women. Clin Chem 1992;38:1981-1987
19. Stenman UH, Tiitinen A, Alfthan H, Valmu L. The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update 2006; 12:769-784 (Pubitemid 44605514)
20. Cole LA, Kardana A. Discordant results in human chorionic gonadotropin assays. Clin Chem 1992; 38:263-270
21. Kovalevskaya G, Birken S, Kakuma T, Schlatterer J, O'Connor JF. Evaluation of nicked human chorionic gonadotropin content in clinical specimens by a specific immunometric assay. Clin Chem 1999;45:68-77. (Pubitemid 29036387)
22. Cole LA, Sutton JM, Higgins TN, Cembrowski GS. Between-method variation in human chorionic gonadotropin test results. Clin Chem 2004;50: 874-882
23. Berger P, Sturgeon C, Bidart JM, Paus E, Gerth R, Niang M, et al. The ISOBM TD-7 workshop on hCG and related molecules: towards useroriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the threedimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumour Biol 2002;23:1-38. (Pubitemid 34225019)
24. McChesney R, Wilcox AJ, O'Connor JF, Weinberg CR, Baird DD, Schlatterer JP, et al. Intact HCG, free HCG beta subunit and HCG beta core fragment: longitudinal patterns in urine during early pregnancy. Hum Reprod 2005;20:928-935 (Pubitemid 40667837)
25. Lempiainen A, Stenman UH, Blomqvist C, Hotakainen K. Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer. Clin Chem 2008;54:1840-1843
26. Cole LA, Butler SA, Khanlian SA, Giddings A, Muller CY, Seckl MJ, Kohorn EI. Gestational trophoblastic diseases; 2: hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol 2006;102:151-159